AFRL completes second Golden Horde demonstration, shifts focus to Colosseum digital weapon ‘ecosystem'

by Richard Scott Mar 22, 2021, 10:24 AM

A second flight test performed under the US Air Force’s Golden Horde networked collaborative weapons programme has seen four testbed munitions communicate and...

A second flight test performed under the US Air Force’s Golden Horde networked collaborative weapons programme has seen four testbed munitions communicate and synchronise to successfully strike multiple ground targets.

Conducted by the Air Force Research Laboratory (AFRL) in conjunction with Scientific Applications & Research Associates, the latest test proved the resolution of weapon software issues that had affected the first Golden Horde demonstration in December 2020.

Collaborative Small Diameter Bombs (CSDBs) are launched from the wing of an F-16 fighter from the Air Force Test Center’s 96th Test Wing at Eglin Air Force Base, Florida. Four of the bombs were dropped during the second flight demonstration of the Golden Horde Vanguard on 19 February. (AFRL)

At the same time, the AFRL has revealed that future Golden Horde activities are being reoriented towards the development of multi-tier digital weapon ‘ecosystem’ known as the Colosseum.

Golden Horde is an Air Force Vanguard programme that integrates datalink radios and collaborative behaviours to allow guided weapon systems to work together dynamically in real time to prioritise and defeat targets. This shared data is used to improve information across an entire group or ‘swarm’ of weapons to defeat adversary defences and improve overall effectiveness.

The second Golden Horde flight test demonstration, executed on 19 February, saw an F-16 aircraft from the Air Force Test Center’s 96th Test Wing release four Collaborative Small Diameter Bomb (CSDB) weapons. The CSDB is a standard GBU-39 SDB I modified to integrate a network collaborative autonomy payload that gives the weapon the ability to dynamically respond to changes in mission parameters without real-time human intervention.

Already a Janes subscriber? Read the full article via the Client Login
Interested in subscribing, see What we do